Evidence map›Paper›PMID 31878947›Full record

ArticleMalaria journal2019

Clinical diagnostic evaluation of HRP2 and pLDH-based rapid diagnostic tests for malaria in an area receiving seasonal malaria chemoprevention in Niger.

Matthew E Coldiron, Bachir Assao, Céline Langendorf, Nathan Sayinzoga-Makombe, Iza Ciglenecki, Roberto de la Tour, Erwan Piriou, Mahaman Yarima Bako, Ann Mumina, Ousmane Guindo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Low frequency ofFrontiers in epidemiology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Matthew E ColdironEpicentre, 8 rue Saint-Sabin, Paris, France. matthew.coldiron@epicentre.msf.org.ORCID http://orcid.org/0000-0002-3345-5971
Bachir AssaoEpicentre, Maradi, Niger.
Céline LangendorfEpicentre, 8 rue Saint-Sabin, Paris, France.
Nathan Sayinzoga-MakombeEpicentre, Maradi, Niger.
Iza CigleneckiMédecins Sans Frontières, 70 rue de Lausanne, Geneva, Switzerland.
Roberto de la TourMédecins Sans Frontières, 70 rue de Lausanne, Geneva, Switzerland.
Erwan PiriouMédecins Sans Frontières, Naritaweg 10, Amsterdam, The Netherlands.
Mahaman Yarima BakoMinistry of Public Health, Magaria, Niger.
Ann MuminaMédecins Sans Frontières, Niamey, Niger.
Ousmane GuindoEpicentre, Maradi, Niger.
Anne-Laure PageEpicentre, 8 rue Saint-Sabin, Paris, France.
Rebecca F GraisEpicentre, 8 rue Saint-Sabin, Paris, France.
United Nations Children's Fund Niger · NEMédecins Sans Frontières · CHEpicentre (South Africa) · ZAMédecins Sans Frontières · NLMinistère de la Santé Publique · NE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRapid diagnostic tests (RDT) for malaria are common, but their performance varies. Tests using histidine-rich protein 2 (HRP2) antigen are most common, and many have high sensitivity. HRP2 tests can remain positive for weeks after treatment, limiting their specificity and usefulness in high-transmission settings. Tests using Plasmodium lactate dehydrogenase (pLDH) have been less widely used but have higher specificity, mostly due to a much shorter time to become negative.

methodsA prospective, health centre-based, diagnostic evaluation of two malaria RDTs was performed in rural Niger during the high malaria transmission season (3-28 October, 2017) and during the low transmission season (28 January-31 March, 2018). All children under 5 years of age presenting with fever (axillary temperature > 37.5 °C) or history of fever in the previous 24 h were eligible. Capillary blood was collected by finger prick. The SD Bioline HRP2 (catalog: 05FK50) and the CareStart pLDH(pan) (catalog: RMNM-02571) were performed in parallel, and thick and thin smears were prepared. Microscopy was performed at Epicentre, Maradi, Niger, with external quality control. The target sample size was 279 children with microscopy-confirmed malaria during each transmission season.

resultsIn the high season, the sensitivity of both tests was estimated at > 99%, but the specificity of both tests was lower: 58.0% (95% CI 52.1-63.8) for the pLDH test and 57.4% (95% CI 51.5-63.1) for the HRP2 test. The positive predictive value was 66.3% (95% CI 61.1-71.2) for both tests. In the low season, the sensitivity of both tests dropped: 91.0% (95% CI 85.3-95.0) for the pLDH test and 85.8% (95% CI 79.3-90.9) for the HRP2 test. The positive predictive value remained low for both tests in the low season: 60.5% (95% CI 53.9-66.8) for the pLDH test and 61.9% (55.0-68.4) for the HRP2 test. Performance was similar across different production lots, gender, age of the children, and, during the high season, time since the most recent distribution of seasonal malaria chemoprevention.

conclusionsThe low specificity of the pLDH RDT in this setting was unexpected and is not easily explained. As the pLDH test continues to be introduced into new settings, the questions raised by this study will need to be addressed.

Indexed as

Antigens, ProtozoanChemopreventionChild, PreschoolDiagnostic Tests, RoutineFemaleHumansInfantInfant, NewbornL-Lactate DehydrogenaseMalaria, FalciparumMaleNigerPlasmodium falciparumProspective StudiesProtozoan ProteinsSeasonsAntigens, ProtozoanHRP-2 antigen, Plasmodium falciparumL-Lactate DehydrogenaseProtozoan ProteinsHistidine-rich protein 2MalariaNigerPlasmodium lactate dehydrogenaseRapid diagnostic test

Identifiers

PMID31878947
PMCPMC6933886
OpenAlexW2997384320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.